SCHEMBL2599449

SCHEMBL2599449

CC=C(O[Si](C)(C)C(C)(C)C)c1cccc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.40
PTGS2 P35354 2/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
PARP1 P09874 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
HTT P42858 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CTSL P07711 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2599448 1.00 PTGS1 (0.40) PTGS1PTGS2CES2CES1PARP1
SCHEMBL15007498 0.83 PARP1 (0.39) PARP1CYP2C19HDAC6MEN1KMT2A
SCHEMBL15007497 0.83 PARP1 (0.39) PARP1CYP2C19HDAC6MEN1KMT2A
SCHEMBL15007508 0.82 C1S (0.41) PARP1NPC1RAB9AHTTMEN1
SCHEMBL1683164 0.82 SLC6A2 (0.38) PARP1HTTCYP2C19ALDH1A1KDM4E
SCHEMBL15007507 0.82 C1S (0.41) PARP1NPC1RAB9AHTTMEN1
SCHEMBL1683161 0.82 SLC6A2 (0.38) PARP1HTTCYP2C19ALDH1A1KDM4E
SCHEMBL2599129 0.81 PRSS1 (0.47) CES2CES1PARP1NPC1RAB9A
SCHEMBL2599124 0.81 PRSS1 (0.47) CES2CES1PARP1NPC1RAB9A
SCHEMBL15007496 0.80 ALDH1A1 (0.34) CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527823-B2 Hydroxybupropion analogues for treating drug dependence RESEARCH TRIANGLE INSTITUTE (US) 2016-12-27 US disclosed
EP-2571859-B1 1-PHENYLMORPHOLINE DERIVATIVES AS HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE RES TRIANGLE INST (US) 2015-07-22 EP disclosed
US-20150141416-A1 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE RESEARCH TRIANGLE INSTITUTE 2015-05-21 US disclosed
US-8906908-B2 Hydroxybupropion analogues for treating drug dependence RESEARCH TRIANGLE INSTITUTE (US) 2014-12-09 US disclosed
US-20130150357-A1 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE RESEARCH TRIANGLE INSTITUTE (US) 2013-06-13 US disclosed
EP-2571859-A2 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE Research Triangle Institute (US) 2013-03-27 EP disclosed
WO-2011146821-A2 1 - PHENYLMORPHOLINE DERIVATIVES AS HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE RESEARCH TRIANGLE INSTITUTE (US) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150357-A1 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE SLC6A2, SLC6A3, HTR3B PTGS1 2839/4885PTGS2 3658/4885CES2 91/4885
US-20150141416-A1 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE SLC6A2, SLC6A3, HTR3B PTGS1 2839/4885PTGS2 3658/4885CES2 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.